Cysteamine-induced duodenal ulcers: a new model to test antiulcer agents.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000818:Animals; D000863:Antacids / Q000627:therapeutic use; D003543:Cysteamine / Q000008:administration & dosage / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000627:therapeutic use; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004381:Duodenal Ulcer / Q000139:chemically induced* / Q000517:prevention & control; D005215:Fasting; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D008026:Ligation; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D011708:Pylorus / Q000502:physiology; D051381:Rats; D012602:Scopolamine Derivatives / Q000627:therapeutic use; D012636:Secretory Rate / Q000187:drug effects; D012737:Sex Factors; D013268:Stimulation, Chemical; D013997:Time Factors
D000863:Antacids; D011453:Prostaglandins; D012602:Scopolamine Derivatives; D003900:Desoxycorticosterone; D003543:Cysteamine; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone